AI and health dominate Super Bowl ads
Super Bowl ad previews are out, and a clear theme is in play: artificial intelligence, telehealth, and GLP-1 weight-loss drugs are front and center. Big brands are pairing familiar faces with new tech and medical services to speed up mainstream adoption. The message is simple-this is how care and daily life will be managed going forward.
Coverage from major outlets points to the same trend: more airtime for digital health platforms and AI tools, backed by celebrities to build trust. See reporting from the Associated Press and CBS News. Alongside the hype, concerns persist about data privacy, misinformation, and the commercialization of care.
What this means for marketers
- Trust transfer is the currency: celebrities make unfamiliar services feel safe. Pair them with plain-language claims and clear disclaimers.
- Engineer the funnel: use the 30-second spot to drive people to owned channels where education, FAQs, and consent happen.
- Measure actions, not applause: track app installs, account creations, telehealth bookings, and refill starts over vanity metrics.
- Be specific on data: state what data you collect, why, and how it's protected-on-screen, not buried in a footer.
- Have a "viral goes sideways" plan: brief spokespeople, prep social replies, and rehearse issue management before kickoff.
What this means for healthcare leaders
- Telehealth is now prime-time: expect higher demand and higher expectations for speed, quality, and clarity.
- GLP-1 demand will spike: align inventory, prior auth workflows, and patient education on risks, benefits, and alternatives.
- Compliance must keep pace: state-by-state telemedicine rules, fair balance in ads, and tight review of celebrity phrasing.
- Prep your front lines: call centers, chat, and clinical staff need consistent scripts to handle ad-driven questions.
- Watch for misinformation: monitor social chatter and correct fast with patient-friendly explainers.
The trust and privacy trade-off
Mass marketing of medical services brings scrutiny. Viewers want convenience without feeling exposed. Put consent first, minimize data collection, and explain how information is used in clear terms.
For anything health-related, credibility beats clever. Use transparent claims, visible risk language, and links to real clinical information-not buzzwords.
Creative patterns showing up in early previews
- Futuristic visuals paired with everyday situations to reduce friction.
- Humor upfront, seriousness in the close-especially for prescription products.
- QR codes and short links that push to app downloads or eligibility checks.
- Split-screen storytelling: "old way" versus "new way" for instant clarity.
Budget and ROI realities
With ad slots costing millions, the spot is only the spark. The return is earned across the landing page, onboarding, care experience, and refill cycle. Tight alignment between media, product, and clinical ops is the difference between buzz and outcomes.
Not every ad is tech or health
Pepsi, Lays, and Budweiser will still lean into nostalgia and feel-good moments. That contrast makes a useful point: novelty pulls attention; familiarity builds comfort. The best healthcare and AI ads borrow from both.
What to watch during the game
- Claims: are they measurable and supported, or vague and hype-filled?
- Disclaimers: are risks legible, audible, and on-screen long enough?
- Data promises: do they say what happens to your info after sign-up?
- Continuity offers: any subscriptions, auto-refills, or monthly fees clearly stated?
- Capacity: will telehealth waits or GLP-1 supply keep up with demand on Monday?
Bottom line
This year's Super Bowl isn't just selling snacks and trucks. It's selling a new default for care and productivity-accessible from your couch, framed by friendly faces, and one tap away. Whether viewers buy in will come down to trust, clarity, and real outcomes.
Keep learning
If you work in marketing or healthcare and want to upskill on practical AI, explore role-specific paths at Complete AI Training.
Your membership also unlocks:
